FDA committee proposes overhaul of perioperative lung cancer trials
The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has called for changes in how clinical trials …
The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has called for changes in how clinical trials …
American biopharmaceutical company Viking Therapeutics is actively developing several candidates aimed at treating metabolic disorders. Among these is VK2735, a …
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the …
Cue Biopharma has instituted strategic restructuring measures with a plan to focus on autoimmune programs and carry out a workforce …
While the topic of clinical trial diversity has been in circulation for some time, it has recently gained traction with …
Calliditas Therapeutics has reported that the Phase IIb TRANSFORM clinical trial of setanaxib, a NOX enzyme inhibitor, in people with …
Highlands Oncology and Paradigm have reported a 45% increase in clinical trial enrolment in Northwest Arkansas, US. This collaboration aims to …
Eisai has adopted Medidata's Clinical Data Studio, which aims to transform and modernising the clinical trial efficiency and patient experience. Launched …
Viridian Therapeutics has announced the completion of subject enrolment for its Phase III THRIVE-2 clinical trial of VRDN-001, aimed at …
The European Commission (EC) has awarded conditional marketing authorisation for Pfizer's DURVEQTIX (fidanacogene elaparvovec), a one-time gene therapy for use …
Non-Hodgkin’s lymphoma (NHL) is a type of cancer that originates in the lymphatic system, part of the body's immune system. …
Ariceum Therapeutics has initiated a Phase I trial for iodine-123 labelled ¹²³I-ATT001 in brain cancer patients, as the company eyes …
The chronic obstructive pulmonary disorder (COPD) market has laid relatively dormant for the past few years until recently. Several biologics which …
Passage Bio has plans to talk with the US Food and Drug Administration (FDA) to initiate trials of its investigative …
Autobahn Therapeutics has secured $100 in an oversubscribed Series C financing round for the commencement of two Phase II clinical …